Sales and Marketing

Showing 15 posts of 11527 posts found.

China sees fresh wave of drug price cuts

September 21, 2012 Manufacturing and Production, Sales and Marketing China, Lunt, NDRC, ageing

China has unveiled yet another round of price cuts to prescription medicines. The price cuts cover more than 200 formulations …

Transgene appoints Nathalie Adda as chief medical officer

September 21, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Nathalie Adda, Transgene

Transgene has announced the appointment of Dr Nathalie Adda as chief medical officer. Responsible for medical and regulatory affairs of …

Merz Pharma slammed by PMCPA

September 21, 2012 Medical Communications, Sales and Marketing ABPI, Merz Pharma, PMCPA

Merz Pharma UK has been rapped over the knuckles for three of the most serious breaches it is possible to …

Almirall’s COPD drug launched in Europe

September 20, 2012 Sales and Marketing Advair, Almirall, Eklira, Genuair, Seretide, Spiriva

Almirall has launched COPD treatment Eklira in Denmark following approval from the European Commission. Phase III trials demonstrated that Eklira …

Teva announces appointment of Prof Itzhak Krinsky

September 20, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Itzhak Krinsky, Teva

Teva has announced the appointment of Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head …

Sanofi cleared in sales row

September 20, 2012 Medical Communications, Sales and Marketing ABPI, CDF, Jevtana, PMCPA, Sanofi

Sanofi has been cleared of any wrongdoing after allegations that it had broken multiple clauses in the ABPI Code of …

Boehringer submits new lung cancer drug

September 20, 2012 Research and Development, Sales and Marketing Boehringer, NSCLC, Roche, Tarceva, afatinib

Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …

Sandra Peterson joins J&J’s executive committee

September 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Sandra Peterson

Sandra Peterson will join Johnson & Johnson on 1 December as Group Worldwide chairman and member of the company’s executive …

Afinitor’s new UK indication launched

September 20, 2012 Sales and Marketing Afinitor, CHMP, Novartis, breast cancer

Novartis’ cancer drug Afinitor has been made available in the UK for patients with the most common form of advanced …

RSA announces new Board members

September 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nick Stephens, RSA executive search

Life sciences executive search and interim management specialists RSA has announced the appointment of Nick Stephens as executive chairman, John …

Silence Therapeutics appoints chief medical adviser

September 19, 2012 Business Services, Research and Development, Sales and Marketing Michael Khan, Silence Therapeutics

Silence Therapeutics has announced the appointment of Michael Khan to its board of directors as chief medical adviser. Dr Khan …

J&J sets up life science centres

September 19, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, R&D, innovation

Johnson & Johnson is to set up what it calls regional innovation centres in a bid to speed up the …

Steven Gillis to join Shire Board of directors

September 19, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Steven Gillis

Shire has announced that Dr Steven Gillis will join the Board of directors in October this year. On joining the …

Salmonson is new chair of CHMP

September 19, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, EMA, MPA, Salmonson

Dr Tomas Salmonson has been elected chair of the Committee for Medicinal Products for Human Use (CHMP) for a three-year …

Circassia appoints Stewart Sharpe as VP Commercial Operations

September 19, 2012 Medical Communications, Research and Development, Sales and Marketing Circassia, Stewart Sharpe

Speciality biopharma firm Circassia has announced the appointment of Stewart Sharpe to the newly-created position of vice president, Commercial Operations. …
The Gateway to Local Adoption Series

Latest content